Randomized Phase II Trial of Trofosfamide vs. Adriamycin in Elderly Patients With Previously Untreated Metastatic Soft Tissue Sarcoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Trofosfamide (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 08 Jan 2013 Biomarkers information updated
- 07 Jan 2013 Planned end date changed from 1 Jun 2011 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.